Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine
Clinical trial NCT04707391 · COMPLETED
Trial details
- NCT number
- NCT04707391
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-25
- Primary completion
- 2023-05-03
- Enrollment
- 1250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.